Northern Trust vs. S&P Global: Which Financial Stock Is a Better Buy in 2026?

Northern Trust is projected to grow sales about 20% in 2026 with a roughly 23% rise in net income, while trading at a cheaper forward P/E of 16.5x versus S&P Global's 20.9x and a lower P/S of 3.9x versus 7.9x. The article argues Northern Trust has a stronger valuation-growth mix, supported by wealth-management demand, AI-driven productivity gains, and expansion into alternative assets. S&P Global remains the higher-quality data and ratings franchise, but the piece ultimately favors Northern Trust as the better 2026 portfolio addition.

Analysis

The cleaner read is not “value vs quality,” but “cyclical financial plumbing vs toll-booth data compounder.” NTRS is levered to a higher-rate, higher-market-activity regime where fee pools and client balances can rebound quickly; if equity markets stay constructive and family-office wins accelerate, earnings can re-accelerate faster than the market expects. The catch is that this is a more operationally sensitive business: modest revenue slippage, a few basis points of margin pressure, or a cyber/compliance incident can erase the valuation gap quickly.

SPGI is still the higher-durability compounder, but the market already pays for that durability. The hidden risk is not demand collapse; it is multiple compression if growth proves merely steady while the cost of cloud, AI governance, and regulatory overhead rises. In other words, SPGI likely remains the better “sleep well” asset, but upside from here depends on sustained pricing power and successful execution around the mobility separation, not just the headline franchise quality.

The contrarian angle is that the market may be underestimating NTRS’s operating leverage to a K-shaped wealth cycle and to private markets penetration. If wealthy households keep allocating more into alternatives and cross-border structures, Northern Trust can grow into a larger share of a niche where trust and service matter more than scale alone. That said, the setup is more attractive for a trade than a permanent compounder: NTRS has more room for positive estimate revisions over the next 2-4 quarters, while SPGI has less room to disappoint but also less room to rerate materially.

Bottom line: this favors a relative-value expression rather than an outright winner-take-all bet. The market is paying a premium for SPGI’s resilience, while NTRS offers better near-term earnings surprise potential if market conditions remain benign and management execution holds.

Key Decisions for Investors

• Long NTRS / short SPGI as a 3-6 month relative-value trade: target ~10-15% spread compression if NTRS revisions surprise to the upside; stop if SPGI re-accelerates or NTRS shows margin erosion.
• Buy NTRS on weakness only, ideally after a 3-5% pullback post-earnings or on a market selloff: risk/reward improves if forward P/E stays near or below mid-teens while growth revisions remain positive.
• Maintain or add SPGI only on pullbacks into a broader market de-risking event: it remains the higher-quality hold, but at current expectations upside is more likely to be single-digit unless the spin-off unlocks incremental multiple expansion.
• For options, consider NTRS call spreads 2-4 months out to express upside from earnings revisions with limited downside; best if realized volatility stays contained and rates remain stable.
• Avoid chasing SPGI here with outright longs unless you are explicitly buying quality defensively; the better risk-adjusted entry is a pair structure rather than standalone exposure.